Results 81 to 90 of about 39,756 (195)
Despite the provision of a mumps vaccination program in Canada for over three decades, mumps has not reached elimination. Instead, a re-emergence has been observed in vaccinated populations, particularly in young adults.
Jasmine Rae Frost +8 more
doaj +1 more source
Booster doses of an inactivated F genotype mumps vaccine enhance immunogenicity in mice
The mumps virus (MuV) causes a highly contagious human disease characterized by swelling of the parotid glands. Although the administration of an attenuated Jeryl Lynn (JL) MuV vaccine shows efficacy in reducing the incidence of MuV infection, sporadic ...
Seo Yeon Kim +5 more
doaj +1 more source
ObjectiveTo evaluate the associations of meteorological factors and ambient air pollutants with the incidence of mumps in Ningxia Hui Autonomous Region, and to provide a reference for the development of early warning and response systems for mumps ...
Xianglong LIU +5 more
doaj +1 more source
Background Despite the inclusion of one dose of measles-mumps-rubella (MMR) vaccination in the Expanded Programme on Immunization (EPI), mumps cases and outbreaks continue to occur.
Dan Wu +10 more
doaj +1 more source
Background: Accurate mumps identification relies on robust genotyping. The research examined swab samples from mumps cases, focusing on cheek mucous membranes, aiming to unravel genetic makeup in the SH gene segment.
Noor R. Abady, Walaa F. Obaid
doaj +1 more source
Immunogenicity and safety of an investigational quadrivalent measles, mumps, rubella, and varicella vaccine in children aged 4-6 years: A phase II, randomized, multi-country trial. [PDF]
Habib MA +9 more
europepmc +1 more source
Mumps disease and vaccination in Africa: A scoping review. [PDF]
Gobe I +4 more
europepmc +1 more source
Genome sequence of a mumps virus isolated from the cerebrospinal fluid of a Vietnamese child with meningitis. [PDF]
Tran XD +5 more
europepmc +1 more source

